110 related articles for article (PubMed ID: 16773806)
21. Blind source separation for the computational analysis of dynamic oncological PET studies.
Thireou T; Pavlopoulos S; Kontaxakis G; Santos A
Oncol Rep; 2006; 15 Spec no.():1007-12. PubMed ID: 16525691
[TBL] [Abstract][Full Text] [Related]
22. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.
Hillner BE; Siegel BA; Liu D; Shields AF; Gareen IF; Hanna L; Stine SH; Coleman RE
J Clin Oncol; 2008 May; 26(13):2155-61. PubMed ID: 18362365
[TBL] [Abstract][Full Text] [Related]
23. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.
Buck AK; Herrmann K; Stargardt T; Dechow T; Krause BJ; Schreyögg J
J Nucl Med Technol; 2010 Mar; 38(1):6-17. PubMed ID: 20197541
[TBL] [Abstract][Full Text] [Related]
24. Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry.
Subramaniam RM; Shields AF; Sachedina A; Hanna L; Duan F; Siegel BA; Hillner BE
Oncologist; 2016 Sep; 21(9):1079-84. PubMed ID: 27401896
[TBL] [Abstract][Full Text] [Related]
25. 18FDG PET in oncology: the best and the worst (Review).
Belhocine T; Spaepen K; Dusart M; Castaigne C; Muylle K; Bourgeois P; Bourgeois D; Dierickx L; Flamen P
Int J Oncol; 2006 May; 28(5):1249-61. PubMed ID: 16596242
[TBL] [Abstract][Full Text] [Related]
26. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
Dimitrakopoulou-Strauss A; Strauss L
Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
[TBL] [Abstract][Full Text] [Related]
27. Significantly Low Effective Dose from 18FDG PET/CT Scans Using Dose Reducing Strategies: "Lesser is Better".
Zaman MU; Fatima N; Zaman A; Zaman U; Tahseen R
Asian Pac J Cancer Prev; 2016; 17(7):3465-8. PubMed ID: 27509993
[TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography and colorectal cancer.
Lin M; Wong K; Ng WL; Shon IH; Morgan M
Crit Rev Oncol Hematol; 2011 Jan; 77(1):30-47. PubMed ID: 20619671
[TBL] [Abstract][Full Text] [Related]
29. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?
Vallabhajosula S; Solnes L; Vallabhajosula B
Semin Nucl Med; 2011 Jul; 41(4):246-64. PubMed ID: 21624560
[TBL] [Abstract][Full Text] [Related]
30. Is positron emission tomography reliable to predict post-chemotherapy retroperitoneal lymph node involvement in advanced germ cell tumors of the testis?
Akbulut Z; Canda AE; Atmaca AF; Caglayan A; Asil E; Balbay MD
Urol J; 2011; 8(2):120-6. PubMed ID: 21656470
[TBL] [Abstract][Full Text] [Related]
31. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
[TBL] [Abstract][Full Text] [Related]
32. Trends in PET Scan Usage for Imaging of Patients Diagnosed With Nonmetastatic Urologic Cancer.
Adejoro O; Alishahi A; Soubra A; Konety B
Clin Genitourin Cancer; 2016 Feb; 14(1):38-47.e1. PubMed ID: 26525859
[TBL] [Abstract][Full Text] [Related]
33. False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.
Culverwell AD; Scarsbrook AF; Chowdhury FU
Clin Radiol; 2011 Apr; 66(4):366-82. PubMed ID: 21356398
[TBL] [Abstract][Full Text] [Related]
34. Standardization and quantification in PET/CT imaging: tracers beyond FDG.
Antunovic L; Rodari M; Rossi P; Chiti A
PET Clin; 2014 Jul; 9(3):259-66. PubMed ID: 25030389
[TBL] [Abstract][Full Text] [Related]
35. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
Reske SN; Kotzerke J
Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
[TBL] [Abstract][Full Text] [Related]
36. [Present state of Positron Emission Tomography in Spain. Results of the survey].
Cabrera A
Rev Esp Med Nucl; 2005; 24(2):136-42. PubMed ID: 15745687
[No Abstract] [Full Text] [Related]
37. An inter-laboratory comparison study of image quality of PET scanners using the NEMA NU 2-2001 procedure for assessment of image quality.
Bergmann H; Dobrozemsky G; Minear G; Nicoletti R; Samal M
Phys Med Biol; 2005 May; 50(10):2193-207. PubMed ID: 15876661
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of new technologies PET/CT nuclear imaging].
Giraldes MR
Acta Med Port; 2010; 23(2):291-310. PubMed ID: 20470481
[TBL] [Abstract][Full Text] [Related]
39. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements.
Cohade C; Wahl RL
Semin Nucl Med; 2003 Jul; 33(3):228-37. PubMed ID: 12931324
[TBL] [Abstract][Full Text] [Related]
40. [Positron emission tomography (PET)--current state of the art and future perspectives].
von Schulthess GK;
Praxis (Bern 1994); 2005 Aug; 94(35):1331-7. PubMed ID: 16171004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
